Deals

CEO of Salonpas Maker Seeks to Take the $2.9 Billion Drug Firm Private

Boxes of Hisamitsu Pharmaceutical’s Salonpas-branded pain relieving patch.Photographer: Hideki Suzuki/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Hideki Suzuki, Taro Fuse, and Kanoko Matsuyama

January 6, 2026 at 1:30 AM UTC

Updated on

January 6, 2026 at 4:30 PM UTC

Hisamitsu Pharmaceutical Co. said it expects to be taken private in a management buyout that values the Japanese maker of pain-relief patches at about ¥457 billion ($2.9 billion).

The offer price of ¥6,082 a share is a roughly 35% premium to Hisamitsu’s unaffected closing price on Monday, before Bloomberg reported that the company was considering a buyout.